Med Sci Monit
A head-to-head comparison trial with 800 patients will give direct results in late 2026
Glatter: Additional approaches to lose weight and manage cardiometabolic aspects of obesity include adherence to the Mediterranean, DASH, or MIND diet, along with adequate strength training, close monitoring of hydration status, and caloric intake to maintain and prevent muscle loss, particularly while taking a GLP-1
Mechanisms controlling pancreatic islet cell function in insulin secretion
Development of GLP-1 Drugs Decades after the discovery of the natural hormone, there are now several available GLP-1 drugsor GLP-1 receptor agoniststhat can be used to treat diabetes, obesity, and other conditions
When to discuss a dose increase If you have been at your current dose for four or more weeks with minimal appetite suppression or weight change, a dose increase is usually the appropriate next step